SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-21-021801
Filing Date
2021-06-03
Accepted
2021-06-03 16:34:29
Documents
1
Period of Report
2021-06-01

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 4054
  Complete submission text file 0000899243-21-021801.txt   5573
Mailing Address 131 DARTMOUTH STREET SUITE 502 BOSTON MA 02116
Business Address 131 DARTMOUTH STREET SUITE 502 BOSTON MA 02116 844-304-2048
Cerevel Therapeutics Holdings, Inc. (Issuer) CIK: 0001805387 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O AEON BIOPHARMA, INC. 4040 MACARTHUR BLVD., SUITE 260 NEWPORT BEACH CA 92660
Business Address
Akamine Scott (Reporting) CIK: 0001816720 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39311 | Film No.: 21992970